23 Jun, 2021 Eighth Annual RNAi Roundtable Series
We are hosting a series of online “RNAi Roundtables” at which Alnylam scientists and program leaders, as well as medical thought leaders, will review recent progress in many of our pipeline programs and platform, and provide perspectives on clinical developments and unmet needs in various therapeutic areas.
Click on any of the RNAi Roundtables below to listen to the webcasts and view presentations from these events.
Zilebesiran (ALN-AGT), in Development for the Treatment of Hypertension
Wednesday, June 30, 10:00 am ET
Patisiran and Vutrisiran, in Development for the Treatment of ATTR Amyloidosis
Friday, July 16, 11:00 am ET
Givosiran, for the Treatment of Acute Hepatic Porphyria
Wednesday, August 4, 1:30 pm ET
Lumasiran, for the Treatment of Primary Hyperoxaluria Type 1
Thursday, August 19, 9:30 am ET (tentative)
Liver-Directed RNAi Pipeline Programs
Monday, September 20, 11:00 am ET
CNS & Extrahepatic RNAi Pipeline Programs
Friday, October 1, 1:30 pm ET